<DOC>
	<DOCNO>NCT01772303</DOCNO>
	<brief_summary>This multicenter , prospective , open-label , outpatient study ass safety efficacy HO/03/03 10µg apply topically daily 24 week 100 subject Hard Heal document chronic wound various etiology ( pressure ulcer , diabetic ulcer , post operational wound surgical incision ulcer rheumatoid arthritis trauma wound ) least 4 week documentation .</brief_summary>
	<brief_title>Safety Efficacy Study HO/03/03 10-40 Micro Grams Treat Hard Heal Wounds</brief_title>
	<detailed_description>All subject wind size 56.25 cm2 ( inclusive ) administer 1 vial 10 ml HO/03/03 10μg per administration . For increase wound size 56.25 cm2 additional vial HO/03/03 10 μg add maximal wound size area 225 cm2 ( measure HealOr central reviewer ) utilize 40µg ( 4 vial ) per administration . 15 min post treatment wound dress accord standard care .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<criteria>Age 18 year old . Chronic wound &lt; 30 % change area Screening Have single / multiple wound ; Have HardtoHeal wound ( ) various etiology Have document medical history significant cardiac , pulmonary , gastrointestinal , endocrine ( Diabetes Mellitus type 1 2 ) , hepatic per physician 's discretion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Pressure Ulcers , diabetic Ulcers , post operational wound</keyword>
</DOC>